4//SEC Filing
Cara Therapeutics, Inc. 4
Accession 0001209191-15-016219
$TVRDCIK 0001346830operating
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 6:00 PM ET
Size
5.3 KB
Accession
0001209191-15-016219
Insider Transaction Report
Form 4
Schoell Josef
Chief Financial Officer
Transactions
- Sale
Common Stock
2015-02-17$10.96/sh−15,000$164,400→ 25,000 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2014.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.91 - $11.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001346830
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 6:00 PM ET
- Size
- 5.3 KB